$T2 Biosystems (TTOO.US)$ NEWS T2 Biosystems Announces First...
NEWS
T2 Biosystems Announces First Quarter 2024 Financial Results
T2 Biosystems, a leader in sepsis detection, announced Q1 2024 financial results, showing 25% growth in sepsis product revenue. They converted $30M debt into equity, signed key agreements, and focused on product development.
25% growth in sepsis product revenue in Q1 2024
Reduced debt by 80% compared to the prior year
Signed key agreements to strengthen the balance sheet
Received FDA clearances for product expansions
Achieved significant progress in the product pipeline
Reduced debt by 80% compared to the prior year
Signed key agreements to strengthen the balance sheet
Received FDA clearances for product expansions
Achieved significant progress in the product pipeline
Net loss of $13.5 million in Q1 2024
Decrease in cash and cash equivalents compared to the prior year
Total outstanding indebtedness reduction by 79% in the past 12 months
Decrease in cash and cash equivalents compared to the prior year
Total outstanding indebtedness reduction by 79% in the past 12 months
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
840Followers
62Following
5574Visitors
Follow